Allison Eddy
Last active: 2/3/2012

  1. Vascular endothelial cadherin modulates renal interstitial fibrosis. Yamaguchi I, Tchao BN, Burger ML, Yamada M, Hyodo T, Giampietro C, Eddy AA (2012) Nephron Exp Nephrol 120(1): e20-31
    › Primary publication · 22126970 (PubMed) · PMC3254033 (PubMed Central)
  2. Mannose receptor 2 attenuates renal fibrosis. López-Guisa JM, Cai X, Collins SJ, Yamaguchi I, Okamura DM, Bugge TH, Isacke CM, Emson CL, Turner SM, Shankland SJ, Eddy AA (2012) J Am Soc Nephrol 23(2): 236-51
    › Primary publication · 22095946 (PubMed) · PMC3269177 (PubMed Central)
  3. Investigating mechanisms of chronic kidney disease in mouse models. Eddy AA, López-Guisa JM, Okamura DM, Yamaguchi I (2012) Pediatr Nephrol 27(8): 1233-47
    › Primary publication · 21695449 (PubMed) · PMC3199379 (PubMed Central)
  4. Albumin-induced apoptosis of glomerular parietal epithelial cells is modulated by extracellular signal-regulated kinase 1/2. Chang AM, Ohse T, Krofft RD, Wu JS, Eddy AA, Pippin JW, Shankland SJ (2012) Nephrol Dial Transplant 27(4): 1330-43
    › Primary publication · 21896500 (PubMed) · PMC3315669 (PubMed Central)
  5. Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease. López-Guisa JM, Rassa AC, Cai X, Collins SJ, Eddy AA (2011) Am J Physiol Renal Physiol 300(5): F1244-54
    › Primary publication · 21270094 (PubMed) · PMC3094052 (PubMed Central)
  6. The TGF-β route to renal fibrosis is not linear: the miR-21 viaduct. Eddy AA (2011) J Am Soc Nephrol 22(9): 1573-5
    › Primary publication · 21836141 (PubMed)
  7. Nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy. Zhang G, Thomas AL, Marshall AL, Kernan KA, Su Y, Zheng Y, Takano J, Saido TC, Eddy AA (2011) Lab Invest 91(1): 106-23
    › Primary publication · 20661225 (PubMed) · PMC3188436 (PubMed Central)
  8. Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis. Okamura DM, Pasichnyk K, Lopez-Guisa JM, Collins S, Hsu DK, Liu FT, Eddy AA (2011) Am J Physiol Renal Physiol 300(1): F245-53
    › Primary publication · 20962111 (PubMed) · PMC3023228 (PubMed Central)
  9. Serine proteases, inhibitors and receptors in renal fibrosis. Eddy AA (2009) Thromb Haemost 101(4): 656-64
    › Primary publication · 19350108 (PubMed) · PMC3136815 (PubMed Central)
  10. CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. Okamura DM, Pennathur S, Pasichnyk K, López-Guisa JM, Collins S, Febbraio M, Heinecke J, Eddy AA (2009) J Am Soc Nephrol 20(3): 495-505
    › Primary publication · 19211715 (PubMed) · PMC2653683 (PubMed Central)